Tenax Historical Financial Ratios
| TENX Stock | USD 6.13 0.13 2.08% |
Tenax Therapeutics is promptly reporting on over 109 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 0.57, Invested Capital of 0.0, Average Payables of 2.5 M or Stock Based Compensation To Revenue of 0.0187 will help investors to properly organize and evaluate Tenax Therapeutics financial condition quickly.
Tenax |
About Tenax Financial Ratios Analysis
Tenax TherapeuticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Tenax Therapeutics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Tenax financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Tenax Therapeutics history.
Tenax Therapeutics Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Tenax Therapeutics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Tenax Therapeutics sales, a figure that is much harder to manipulate than other Tenax Therapeutics multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Tenax Therapeutics dividend as a percentage of Tenax Therapeutics stock price. Tenax Therapeutics dividend yield is a measure of Tenax Therapeutics stock productivity, which can be interpreted as interest rate earned on an Tenax Therapeutics investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Most ratios from Tenax Therapeutics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Tenax Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tenax Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Tenax Stock please use our How to Invest in Tenax Therapeutics guide.At this time, Tenax Therapeutics' Capex To Revenue is fairly stable compared to the past year. Days Payables Outstanding is likely to rise to about 94.5 K in 2025, whereas Days Sales Outstanding is likely to drop 166.06 in 2025.
| 2024 | 2025 (projected) | Dividend Yield | 3.72 | 3.31 | Price To Sales Ratio | 134.5K | 141.3K |
Tenax Therapeutics fundamentals Correlations
Click cells to compare fundamentals
Tenax Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Tenax Therapeutics fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Ptb Ratio | 4.17 | 5.04 | 2.19 | 0.67 | 10.28 | 10.79 | |
| Book Value Per Share | 714.04 | 330.07 | 81.17 | 32.65 | 0.6 | 0.57 | |
| Free Cash Flow Yield | (0.48) | (0.51) | (3.68) | (1.08) | (0.0157) | (0.0165) | |
| Operating Cash Flow Per Share | (1.4K) | (844.18) | (653.19) | (23.8) | (0.097) | (0.1) | |
| Capex To Depreciation | 0.0304 | 0.0482 | 0.0205 | 0.38 | 0.43 | 0.41 | |
| Pb Ratio | 4.17 | 5.04 | 2.19 | 0.67 | 10.28 | 10.79 | |
| Free Cash Flow Per Share | (1.4K) | (844.59) | (653.32) | (23.8) | (0.097) | (0.1) | |
| Roic | (2.01) | (7.27) | (4.8) | (0.96) | (1.1) | (1.16) | |
| Net Income Per Share | (27.1) | (1.5K) | (2.5K) | (600.46) | (31.09) | (0.12) | |
| Payables Turnover | 0.15 | 0.13 | 0.25 | 0.003651 | 0.003286 | 0.003451 | |
| Cash Per Share | 1.0K | 434.21 | 115.47 | 39.48 | 0.62 | 0.59 | |
| Pocfratio | (2.08) | (1.97) | (0.27) | (0.92) | (63.83) | (67.02) | |
| Capex To Operating Cash Flow | (3.76E-4) | (4.84E-4) | (1.93E-4) | (4.82E-4) | (4.33E-4) | (4.55E-4) | |
| Pfcf Ratio | (2.08) | (1.97) | (0.27) | (0.92) | (63.83) | (67.02) | |
| Days Payables Outstanding | 2.4K | 2.9K | 1.4K | 100.0K | 90.0K | 94.5K | |
| Income Quality | 0.94 | 0.33 | 1.09 | 0.77 | 0.84 | 0.54 | |
| Roe | (2.13) | (7.71) | (7.4) | (0.95) | (0.19) | (0.18) | |
| Ev To Operating Cash Flow | (1.44) | (1.48) | (0.16) | 0.65 | (57.42) | (60.29) | |
| Pe Ratio | (1.95) | (0.65) | (0.3) | (0.71) | (53.71) | (56.39) | |
| Return On Tangible Assets | (1.44) | (5.46) | (3.24) | (0.66) | (0.18) | (0.19) | |
| Ev To Free Cash Flow | (1.44) | (1.48) | (0.16) | 0.65 | (57.42) | (60.29) | |
| Earnings Yield | (0.51) | (1.53) | (3.38) | (1.42) | (0.0186) | (0.0196) | |
| Net Debt To E B I T D A | 0.61 | 0.16 | 0.12 | 1.13 | 1.02 | 1.07 | |
| Current Ratio | 3.21 | 3.64 | 1.74 | 3.26 | 20.6 | 21.63 | |
| Tangible Book Value Per Share | 714.04 | 330.07 | 81.17 | 32.65 | 0.6 | 0.57 | |
| Shareholders Equity Per Share | 714.04 | 330.07 | 81.17 | 32.65 | 0.6 | 0.57 | |
| Debt To Equity | 0.0659 | 0.0685 | 0.54 | 0.0619 | 0.0557 | 0.0585 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for Tenax Stock Analysis
When running Tenax Therapeutics' price analysis, check to measure Tenax Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenax Therapeutics is operating at the current time. Most of Tenax Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tenax Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenax Therapeutics' price. Additionally, you may evaluate how the addition of Tenax Therapeutics to your portfolios can decrease your overall portfolio volatility.